Determination of loratadine in human plasma by HPLC with fluorescence detector and study on its bioavailability

Yaoxue Xuebao

Volumn 39, Issue 2, 2004, Pages 123-126

  Xu, Xiao Jie ^a   Shang, Er Xin ^a   Qiu, Fu Rong ^b   Mao, Guo Guang ^b   Xiang, Bing Ren ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

Author keywords

Bioavailability; Fluorescence detection; HPLC; Loratadine

Indexed keywords

ACETIC ACID; ACETONITRILE; CLOMIPRAMINE; LORATADINE; TRIETHYLAMINE; WATER; HISTAMINE H1 RECEPTOR ANTAGONIST;

ANALYTICAL EQUIPMENT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; TABLET FORMULATION; BIOAVAILABILITY; BLOOD; FLUORESCENCE; METHODOLOGY;

AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE;

EID: 3242764604     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Batenhorst RL, Batenhorst AS, Graves DA, et al. Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placebo [J]. Eur J Clin Pharmacol, 1986, 31(2) : 247-250.
2. Johnson R, Christensen J, Lin CC. Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen-phosphorus detector [J]. J Chromatogr B Biomed Appl, 1994, 657(1) : 125-131.
3. Kunicki PK. Determination of loratadine in human plasma by high-performance liquid chromatographic method with ultraviolet detection [J]. J Chromatogr B Biomed Sci Appl, 2001, 755(1-2) : 331-335.
4. Sutherland FC, de Jager AD, Badenhorst D. Sensitive liquid chromatography-tandem mass speclrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma [J]. J Chromatogr A, 2001, 914(1 - 2) : 37-43.
5. Zhong D, Blume H. HPLC-determination of loratadine and its active metabolite descarboethoxyloratadine in human plasma [J]. Pharmazie, 1994, 49(10) : 736-739.
6. Holeman JA, Danielson ND. Liquid chromatography ofantihistamines using post-column tris (2, 2-bipyidine)] ruthenium (III) ehemiluminescence detection [J]. J Chromatogr A, 1994, 679(2) : 277-284.
7. Liu YX, Yao C, Chen QG, et al. Equivalence analysis for multiple cross-over design of bioavailabilily trials [J]. Chin J Clin Pharmacol, 2002, 18(3) : 119-223.